VRTX
Vertex Pharmaceuticals Inc
NASDAQ: VRTX · HEALTHCARE · BIOTECHNOLOGY
$427.38
+0.98% today
Updated 2026-04-30
Market cap
$108.71B
P/E ratio
27.93
P/S ratio
9.06x
EPS (TTM)
$15.30
Dividend yield
—
52W range
$363 – $508
Volume
1.3M
Vertex Pharmaceuticals Inc (VRTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $921.58M | $601.48M | $980.48M | $1.96B | $1.73B | $2.20B | $2.76B | $2.32B | $2.34B | $2.50B | $2.89B | $3.55B | $6.25B | $8.32B | $11.75B | $13.43B | $18.15B | $22.73B | $22.53B | $26.14B |
| Cash & equivalents | $213.17M | $355.66M | $389.12M | $446.66M | $243.20M | $475.32M | $489.41M | $569.30M | $625.26M | $714.77M | $1.18B | $1.67B | $2.65B | $3.11B | $5.99B | $6.79B | $10.50B | $10.37B | $4.57B | $5.09B |
| Current assets | $771.41M | $496.85M | $867.58M | $1.31B | $1.06B | $1.33B | $1.59B | $1.59B | $1.55B | $1.36B | $1.76B | $2.48B | $3.70B | $4.82B | $8.13B | $9.56B | $13.23B | $14.14B | $9.60B | $11.20B |
| Total liabilities | $415.64M | $330.18M | $741.61M | $859.14M | $1.22B | $1.24B | $1.52B | $962.64M | $1.24B | $1.40B | $1.56B | $1.50B | $1.81B | $2.23B | $3.06B | $3.33B | $4.24B | $5.15B | $6.12B | $7.48B |
| Current liabilities | $251.01M | $199.28M | $216.56M | $284.88M | $474.78M | $838.77M | $432.62M | $397.83M | $368.25M | $506.35M | $7.95M | $807.26M | $715.48M | $1.33B | $1.88B | $2.14B | $2.74B | $3.55B | $3.56B | $3.86B |
| Long-term debt | $20.00M | — | $287.50M | $121.77M | $400.00M | $455.95M | $668.03M | $440.94M | $753.64M | $696.58M | $486.36M | $563.41M | $561.89M | — | — | — | — | — | — | — |
| Shareholder equity | $505.94M | $271.30M | $238.87M | $1.10B | $503.97M | $786.84M | $999.18M | $1.36B | $1.08B | $1.09B | $1.34B | $2.04B | $4.44B | $6.09B | $8.69B | $10.10B | $13.91B | $17.58B | $16.41B | $18.67B |
| Retained earnings | $-1.20B | $-1.59B | $-2.05B | $-2.69B | $-3.44B | $-3.41B | $-3.52B | $-3.97B | $-4.71B | $-5.26B | $-5.37B | $-5.12B | $-2.99B | $-1.85B | $858.67M | $3.20B | $6.52B | $10.14B | $9.61B | $13.56B |
| Accounts receivable | $62.92M | $31.32M | $23.49M | $9.60M | $12.53M | $183.13M | $143.25M | $85.52M | $90.06M | $177.64M | $201.08M | $281.34M | $409.69M | $633.52M | $885.40M | $1.14B | $1.44B | $1.56B | $1.61B | $2.05B |
| Inventory | — | — | — | $8000.00 | $0.00 | $112.43M | $30.46M | $14.15M | $30.85M | $56.08M | $77.60M | $111.83M | $124.36M | $167.50M | $280.78M | $353.10M | $460.60M | $738.80M | $1.21B | $1.69B |
| Goodwill | — | — | — | $26.10M | $26.10M | $30.99M | $30.99M | $30.99M | $39.91M | $50.38M | $50.38M | $50.38M | $50.38M | $1.00B | $1.00B | $1.00B | $1.09B | $1.09B | $1.09B | $1.09B |